2
|
Martin-Brevet S, Rodríguez-Herreros B, Nielsen JA, Moreau C, Modenato C, Maillard AM, Pain A, Richetin S, Jønch AE, Qureshi AY, Zürcher NR, Conus P, Chung WK, Sherr EH, Spiro JE, Kherif F, Beckmann JS, Hadjikhani N, Reymond A, Buckner RL, Draganski B, Jacquemont S, Arveiler B, Baujat G, Sloan-Béna F, Belfiore M, Bonneau D, Bouquillon S, Boute O, Brusco A, Busa T, Caberg JH, Campion D, Colombert V, Cordier MP, David A, Debray FG, Delrue MA, Doco-Fenzy M, Dunkhase-Heinl U, Edery P, Fagerberg C, Faivre L, Forzano F, Genevieve D, Gérard M, Giachino D, Guichet A, Guillin O, Héron D, Isidor B, Jacquette A, Jaillard S, Journel H, Keren B, Lacombe D, Lebon S, Le Caignec C, Lemaître MP, Lespinasse J, Mathieu-Dramart M, Mercier S, Mignot C, Missirian C, Petit F, Pilekær Sørensen K, Pinson L, Plessis G, Prieur F, Rooryck-Thambo C, Rossi M, Sanlaville D, Schlott Kristiansen B, Schluth-Bolard C, Till M, Van Haelst M, Van Maldergem L, Alupay H, Aaronson B, Ackerman S, Ankenman K, Anwar A, Atwell C, Bowe A, Beaudet AL, Benedetti M, Berg J, Berman J, Berry LN, Bibb AL, Blaskey L, Brennan J, Brewton CM, Buckner R, Bukshpun P, Burko J, Cali P, Cerban B, Chang Y, Cheong M, Chow V, Chu Z, Chudnovskaya D, Cornew L, Dale C, Dell J, Dempsey AG, Deschamps T, Earl R, Edgar J, Elgin J, Olson JE, Evans YL, Findlay A, Fischbach GD, Fisk C, Fregeau B, Gaetz B, Gaetz L, Garza S, Gerdts J, Glenn O, Gobuty SE, Golembski R, Greenup M, Heiken K, Hines K, Hinkley L, Jackson FI, Jenkins J, Jeremy RJ, Johnson K, Kanne SM, Kessler S, Khan SY, Ku M, Kuschner E, Laakman AL, Lam P, Lasala MW, Lee H, LaGuerre K, Levy S, Cavanagh AL, Llorens AV, Campe KL, Luks TL, Marco EJ, Martin S, Martin AJ, Marzano G, Masson C, McGovern KE, McNally Keehn R, Miller DT, Miller FK, Moss TJ, Murray R, Nagarajan SS, Nowell KP, Owen J, Paal AM, Packer A, Page PZ, Paul BM, Peters A, Peterson D, Poduri A, Pojman NJ, Porche K, Proud MB, Qasmieh S, Ramocki MB, Reilly B, Roberts TP, Shaw D, Sinha T, Smith-Packard B, Gallagher AS, Swarnakar V, Thieu T, Triantafallou C, Vaughan R, Wakahiro M, Wallace A, Ward T, Wenegrat J, Wolken A. Quantifying the Effects of 16p11.2 Copy Number Variants on Brain Structure: A Multisite Genetic-First Study. Biol Psychiatry 2018; 84:253-264. [PMID: 29778275 DOI: 10.1016/j.biopsych.2018.02.1176] [Citation(s) in RCA: 45] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/18/2017] [Revised: 02/01/2018] [Accepted: 02/24/2018] [Indexed: 12/25/2022]
Abstract
BACKGROUND 16p11.2 breakpoint 4 to 5 copy number variants (CNVs) increase the risk for developing autism spectrum disorder, schizophrenia, and language and cognitive impairment. In this multisite study, we aimed to quantify the effect of 16p11.2 CNVs on brain structure. METHODS Using voxel- and surface-based brain morphometric methods, we analyzed structural magnetic resonance imaging collected at seven sites from 78 individuals with a deletion, 71 individuals with a duplication, and 212 individuals without a CNV. RESULTS Beyond the 16p11.2-related mirror effect on global brain morphometry, we observe regional mirror differences in the insula (deletion > control > duplication). Other regions are preferentially affected by either the deletion or the duplication: the calcarine cortex and transverse temporal gyrus (deletion > control; Cohen's d > 1), the superior and middle temporal gyri (deletion < control; Cohen's d < -1), and the caudate and hippocampus (control > duplication; -0.5 > Cohen's d > -1). Measures of cognition, language, and social responsiveness and the presence of psychiatric diagnoses do not influence these results. CONCLUSIONS The global and regional effects on brain morphometry due to 16p11.2 CNVs generalize across site, computational method, age, and sex. Effect sizes on neuroimaging and cognitive traits are comparable. Findings partially overlap with results of meta-analyses performed across psychiatric disorders. However, the lack of correlation between morphometric and clinical measures suggests that CNV-associated brain changes contribute to clinical manifestations but require additional factors for the development of the disorder. These findings highlight the power of genetic risk factors as a complement to studying groups defined by behavioral criteria.
Collapse
Affiliation(s)
- Sandra Martin-Brevet
- Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; Laboratoire de Recherche en Neuroimagerie, Département des neurosciences cliniques, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
| | - Borja Rodríguez-Herreros
- Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; CHU Sainte-Justine Research Center, Université de Montréal, Montréal, Quebec, Canada
| | - Jared A Nielsen
- Department of Psychology, Harvard University, Cambridge, Massachusetts; Center for Brain Science, Harvard University, Cambridge, Massachusetts; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts
| | - Clara Moreau
- CHU Sainte-Justine Research Center, Université de Montréal, Montréal, Quebec, Canada
| | - Claudia Modenato
- Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; Laboratoire de Recherche en Neuroimagerie, Département des neurosciences cliniques, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
| | - Anne M Maillard
- Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; Centre Cantonal Autisme, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
| | - Aurélie Pain
- Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; Centre Cantonal Autisme, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
| | - Sonia Richetin
- Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
| | - Aia E Jønch
- CHU Sainte-Justine Research Center, Université de Montréal, Montréal, Quebec, Canada; Department of Clinical Genetics, Odense University Hospital, Odense, Denmark; Human Genetics, Department of Clinical Research, University of Southern Denmark, Odense, Denmark
| | - Abid Y Qureshi
- Center for Brain Science, Harvard University, Cambridge, Massachusetts; Department of Neurology, University of Kansas Medical Center, Kansas City, KS
| | - Nicole R Zürcher
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
| | - Philippe Conus
- Service of General Psychiatry, Department of Psychiatry, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
| | | | | | - Wendy K Chung
- Simons Foundation, New York, New York; Departments of Pediatrics and Medicine, Columbia University, New York, New York
| | - Elliott H Sherr
- Department of Neurology, Department of Pediatrics, and Weill Institute for Neurosciences, University of California, San Francisco, California
| | | | - Ferath Kherif
- Laboratoire de Recherche en Neuroimagerie, Département des neurosciences cliniques, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
| | - Jacques S Beckmann
- Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland
| | - Nouchine Hadjikhani
- Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Gillberg Neuropsychiatry Centre, University of Gothenburg, Gothenburg, Sweden
| | - Alexandre Reymond
- Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland
| | - Randy L Buckner
- Department of Psychology, Harvard University, Cambridge, Massachusetts; Center for Brain Science, Harvard University, Cambridge, Massachusetts; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts; Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
| | - Bogdan Draganski
- Laboratoire de Recherche en Neuroimagerie, Département des neurosciences cliniques, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; Department of Neurology, Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany
| | - Sébastien Jacquemont
- Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Lausanne, Switzerland; CHU Sainte-Justine Research Center, Université de Montréal, Montréal, Quebec, Canada.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
3
|
Owen JP, Bukshpun P, Pojman N, Thieu T, Chen Q, Lee J, D'Angelo D, Glenn OA, Hunter JV, Berman JI, Roberts TP, Buckner R, Nagarajan SS, Mukherjee P, Sherr EH. Brain MR Imaging Findings and Associated Outcomes in Carriers of the Reciprocal Copy Number Variation at 16p11.2. Radiology 2017; 286:217-226. [PMID: 28786752 DOI: 10.1148/radiol.2017162934] [Citation(s) in RCA: 22] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Purpose To identify developmental neuroradiologic findings in a large cohort of carriers who have deletion and duplication at 16p11.2 (one of the most common genetic causes of autism spectrum disorder [ASD]) and assess how these features are associated with behavioral and cognitive outcomes. Materials and Methods Seventy-nine carriers of a deletion at 16p11.2 (referred to as deletion carriers; age range, 1-48 years; mean age, 12.3 years; 42 male patients), 79 carriers of a duplication at 16p11.2 (referred to as duplication carriers; age range, 1-63 years; mean age, 24.8 years; 43 male patients), 64 unaffected family members (referred to as familial noncarriers; age range, 1-46 years; mean age, 11.7 years; 31 male participants), and 109 population control participants (age range, 6-64 years; mean age, 25.5 years; 64 male participants) were enrolled in this cross-sectional study. Participants underwent structural magnetic resonance (MR) imaging and completed cognitive and behavioral tests. MR images were reviewed for development-related abnormalities by neuroradiologists. Differences in frequency were assessed with a Fisher exact test corrected for multiple comparisons. Unsupervised machine learning was used to cluster radiologic features and an association between clusters and cognitive and behavioral scores from IQ testing, and parental measures of development were tested by using analysis of covariance. Volumetric analysis with automated segmentation was used to confirm radiologic interpretation. Results For deletion carriers, the most prominent features were dysmorphic and thicker corpora callosa compared with familial noncarriers and population control participants (16%; P < .001 and P < .001, respectively) and a greater likelihood of cerebellar tonsillar ectopia (30.7%; P < .002 and P < .001, respectively) and Chiari I malformations (9.3%; P < .299 and P < .002, respectively). For duplication carriers, the most salient findings compared with familial noncarriers and population control participants were reciprocally thinner corpora callosa (18.6%; P < .003 and P < .001, respectively), decreased white matter volume (22.9%; P < .001, and P < .001, respectively), and increased ventricular volume (24.3%; P < .001 and P < .001, respectively). By comparing cognitive assessments to imaging findings, the presence of any imaging feature associated with deletion carriers indicated worse daily living, communication, and social skills compared with deletion carriers without any radiologic abnormalities (P < .005, P < .002, and P < .004, respectively). For the duplication carriers, presence of decreased white matter, callosal volume, and/or increased ventricle size was associated with decreased full-scale and verbal IQ scores compared with duplication carriers without these findings (P < .007 and P < .004, respectively). Conclusion In two genetically related cohorts at high risk for ASD, reciprocal neuroanatomic abnormalities were found and determined to be associated with cognitive and behavioral impairments. © RSNA, 2017 Online supplemental material is available for this article.
Collapse
Affiliation(s)
- Julia P Owen
- From the Departments of Radiology (J.P.O., O.A.G., S.S.N., P.M.) and Neurology (P.B., N.P., T.T., E.H.S.), University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, CA 94158; Department of Biostatistics, Columbia University, New York, NY (Q.C., J.L., D.D.); Department of Medicine and Pediatrics, Baylor School of Medicine, Houston, Tex (J.V.H.); Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pa (J.I.B., T.P.R.); and Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Mass (R.B.)
| | - Polina Bukshpun
- From the Departments of Radiology (J.P.O., O.A.G., S.S.N., P.M.) and Neurology (P.B., N.P., T.T., E.H.S.), University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, CA 94158; Department of Biostatistics, Columbia University, New York, NY (Q.C., J.L., D.D.); Department of Medicine and Pediatrics, Baylor School of Medicine, Houston, Tex (J.V.H.); Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pa (J.I.B., T.P.R.); and Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Mass (R.B.)
| | - Nicholas Pojman
- From the Departments of Radiology (J.P.O., O.A.G., S.S.N., P.M.) and Neurology (P.B., N.P., T.T., E.H.S.), University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, CA 94158; Department of Biostatistics, Columbia University, New York, NY (Q.C., J.L., D.D.); Department of Medicine and Pediatrics, Baylor School of Medicine, Houston, Tex (J.V.H.); Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pa (J.I.B., T.P.R.); and Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Mass (R.B.)
| | - Tony Thieu
- From the Departments of Radiology (J.P.O., O.A.G., S.S.N., P.M.) and Neurology (P.B., N.P., T.T., E.H.S.), University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, CA 94158; Department of Biostatistics, Columbia University, New York, NY (Q.C., J.L., D.D.); Department of Medicine and Pediatrics, Baylor School of Medicine, Houston, Tex (J.V.H.); Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pa (J.I.B., T.P.R.); and Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Mass (R.B.)
| | - Qixuan Chen
- From the Departments of Radiology (J.P.O., O.A.G., S.S.N., P.M.) and Neurology (P.B., N.P., T.T., E.H.S.), University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, CA 94158; Department of Biostatistics, Columbia University, New York, NY (Q.C., J.L., D.D.); Department of Medicine and Pediatrics, Baylor School of Medicine, Houston, Tex (J.V.H.); Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pa (J.I.B., T.P.R.); and Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Mass (R.B.)
| | - Jihui Lee
- From the Departments of Radiology (J.P.O., O.A.G., S.S.N., P.M.) and Neurology (P.B., N.P., T.T., E.H.S.), University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, CA 94158; Department of Biostatistics, Columbia University, New York, NY (Q.C., J.L., D.D.); Department of Medicine and Pediatrics, Baylor School of Medicine, Houston, Tex (J.V.H.); Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pa (J.I.B., T.P.R.); and Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Mass (R.B.)
| | - Debra D'Angelo
- From the Departments of Radiology (J.P.O., O.A.G., S.S.N., P.M.) and Neurology (P.B., N.P., T.T., E.H.S.), University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, CA 94158; Department of Biostatistics, Columbia University, New York, NY (Q.C., J.L., D.D.); Department of Medicine and Pediatrics, Baylor School of Medicine, Houston, Tex (J.V.H.); Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pa (J.I.B., T.P.R.); and Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Mass (R.B.)
| | - Orit A Glenn
- From the Departments of Radiology (J.P.O., O.A.G., S.S.N., P.M.) and Neurology (P.B., N.P., T.T., E.H.S.), University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, CA 94158; Department of Biostatistics, Columbia University, New York, NY (Q.C., J.L., D.D.); Department of Medicine and Pediatrics, Baylor School of Medicine, Houston, Tex (J.V.H.); Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pa (J.I.B., T.P.R.); and Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Mass (R.B.)
| | - Jill V Hunter
- From the Departments of Radiology (J.P.O., O.A.G., S.S.N., P.M.) and Neurology (P.B., N.P., T.T., E.H.S.), University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, CA 94158; Department of Biostatistics, Columbia University, New York, NY (Q.C., J.L., D.D.); Department of Medicine and Pediatrics, Baylor School of Medicine, Houston, Tex (J.V.H.); Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pa (J.I.B., T.P.R.); and Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Mass (R.B.)
| | - Jeffrey I Berman
- From the Departments of Radiology (J.P.O., O.A.G., S.S.N., P.M.) and Neurology (P.B., N.P., T.T., E.H.S.), University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, CA 94158; Department of Biostatistics, Columbia University, New York, NY (Q.C., J.L., D.D.); Department of Medicine and Pediatrics, Baylor School of Medicine, Houston, Tex (J.V.H.); Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pa (J.I.B., T.P.R.); and Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Mass (R.B.)
| | - Timothy P Roberts
- From the Departments of Radiology (J.P.O., O.A.G., S.S.N., P.M.) and Neurology (P.B., N.P., T.T., E.H.S.), University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, CA 94158; Department of Biostatistics, Columbia University, New York, NY (Q.C., J.L., D.D.); Department of Medicine and Pediatrics, Baylor School of Medicine, Houston, Tex (J.V.H.); Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pa (J.I.B., T.P.R.); and Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Mass (R.B.)
| | - Randy Buckner
- From the Departments of Radiology (J.P.O., O.A.G., S.S.N., P.M.) and Neurology (P.B., N.P., T.T., E.H.S.), University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, CA 94158; Department of Biostatistics, Columbia University, New York, NY (Q.C., J.L., D.D.); Department of Medicine and Pediatrics, Baylor School of Medicine, Houston, Tex (J.V.H.); Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pa (J.I.B., T.P.R.); and Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Mass (R.B.)
| | - Srikantan S Nagarajan
- From the Departments of Radiology (J.P.O., O.A.G., S.S.N., P.M.) and Neurology (P.B., N.P., T.T., E.H.S.), University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, CA 94158; Department of Biostatistics, Columbia University, New York, NY (Q.C., J.L., D.D.); Department of Medicine and Pediatrics, Baylor School of Medicine, Houston, Tex (J.V.H.); Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pa (J.I.B., T.P.R.); and Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Mass (R.B.)
| | - Pratik Mukherjee
- From the Departments of Radiology (J.P.O., O.A.G., S.S.N., P.M.) and Neurology (P.B., N.P., T.T., E.H.S.), University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, CA 94158; Department of Biostatistics, Columbia University, New York, NY (Q.C., J.L., D.D.); Department of Medicine and Pediatrics, Baylor School of Medicine, Houston, Tex (J.V.H.); Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pa (J.I.B., T.P.R.); and Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Mass (R.B.)
| | - Elliott H Sherr
- From the Departments of Radiology (J.P.O., O.A.G., S.S.N., P.M.) and Neurology (P.B., N.P., T.T., E.H.S.), University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, CA 94158; Department of Biostatistics, Columbia University, New York, NY (Q.C., J.L., D.D.); Department of Medicine and Pediatrics, Baylor School of Medicine, Houston, Tex (J.V.H.); Department of Radiology, Children's Hospital of Philadelphia, Philadelphia, Pa (J.I.B., T.P.R.); and Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, Charlestown, Mass (R.B.)
| |
Collapse
|
4
|
Chang YS, Owen JP, Pojman NJ, Thieu T, Bukshpun P, Wakahiro MLJ, Marco EJ, Berman JI, Spiro JE, Chung WK, Buckner RL, Roberts TPL, Nagarajan SS, Sherr EH, Mukherjee P. Reciprocal white matter alterations due to 16p11.2 chromosomal deletions versus duplications. Hum Brain Mapp 2016; 37:2833-48. [PMID: 27219475 DOI: 10.1002/hbm.23211] [Citation(s) in RCA: 31] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2015] [Revised: 03/28/2016] [Accepted: 03/31/2016] [Indexed: 01/11/2023] Open
Abstract
Copy number variants at the 16p11.2 chromosomal locus are associated with several neuropsychiatric disorders, including autism, schizophrenia, bipolar disorder, attention-deficit hyperactivity disorder, and speech and language disorders. A gene dosage dependence has been suggested, with 16p11.2 deletion carriers demonstrating higher body mass index and head circumference, and 16p11.2 duplication carriers demonstrating lower body mass index and head circumference. Here, we use diffusion tensor imaging to elucidate this reciprocal relationship in white matter organization, showing widespread increases of fractional anisotropy throughout the supratentorial white matter in pediatric deletion carriers and, in contrast, extensive decreases of white matter fractional anisotropy in pediatric and adult duplication carriers. We find associations of these white matter alterations with cognitive and behavioral impairments. We further demonstrate the value of imaging metrics for characterizing the copy number variant phenotype by employing linear discriminant analysis to predict the gene dosage status of the study subjects. These results show an effect of 16p11.2 gene dosage on white matter microstructure, and further suggest that opposite changes in diffusion tensor imaging metrics can lead to similar cognitive and behavioral deficits. Given the large effect sizes found in this study, our results support the view that specific genetic variations are more strongly associated with specific brain alterations than are shared neuropsychiatric diagnoses. Hum Brain Mapp 37:2833-2848, 2016. © 2016 Wiley Periodicals, Inc.
Collapse
Affiliation(s)
- Yi Shin Chang
- Department of Radiology and Biomedical Imaging, University of California, San Francisco, 185 Berry Street, San Francisco, California, 94107
| | - Julia P Owen
- Department of Radiology and Biomedical Imaging, University of California, San Francisco, 185 Berry Street, San Francisco, California, 94107.,Program in Bioengineering, University of California, San Francisco, 1700 4th St, San Francisco, California, 94158
| | - Nicholas J Pojman
- Department of Neurology, University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, California, 94158
| | - Tony Thieu
- Department of Neurology, University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, California, 94158
| | - Polina Bukshpun
- Department of Neurology, University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, California, 94158
| | - Mari L J Wakahiro
- Department of Neurology, University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, California, 94158
| | - Elysa J Marco
- Department of Neurology, University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, California, 94158
| | - Jeffrey I Berman
- Department of Radiology, Children's Hospital of Philadelphia, Wood Bldg, Suite 2115, Philadelphia, Pennsylvania, 19104
| | - John E Spiro
- Simons Foundation, 160 Fifth Avenue, 7th Floor, New York, New York, 10010
| | - Wendy K Chung
- Departments of Pediatrics and Medicine, Columbia University Medical Center, New York, New York, 10032
| | - Randy L Buckner
- Center for Brain Science, Harvard University, 52 Oxford Street, Cambridge, Massachusetts, 02138
| | - Timothy P L Roberts
- Department of Radiology, Children's Hospital of Philadelphia, Wood Bldg, Suite 2115, Philadelphia, Pennsylvania, 19104
| | - Srikantan S Nagarajan
- Department of Radiology and Biomedical Imaging, University of California, San Francisco, 185 Berry Street, San Francisco, California, 94107.,Program in Bioengineering, University of California, San Francisco, 1700 4th St, San Francisco, California, 94158
| | - Elliott H Sherr
- Department of Neurology, University of California, San Francisco, 675 Nelson Rising Lane, San Francisco, California, 94158
| | - Pratik Mukherjee
- Department of Radiology and Biomedical Imaging, University of California, San Francisco, 185 Berry Street, San Francisco, California, 94107.,Program in Bioengineering, University of California, San Francisco, 1700 4th St, San Francisco, California, 94158
| |
Collapse
|
5
|
Gandal MJ, Sisti J, Klook K, Ortinski PI, Leitman V, Liang Y, Thieu T, Anderson R, Pierce RC, Jonak G, Gur RE, Carlson G, Siegel SJ. GABAB-mediated rescue of altered excitatory-inhibitory balance, gamma synchrony and behavioral deficits following constitutive NMDAR-hypofunction. Transl Psychiatry 2012; 2:e142. [PMID: 22806213 PMCID: PMC3410621 DOI: 10.1038/tp.2012.69] [Citation(s) in RCA: 130] [Impact Index Per Article: 10.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/18/2022] Open
Abstract
Reduced N-methyl-D-aspartate-receptor (NMDAR) signaling has been associated with schizophrenia, autism and intellectual disability. NMDAR-hypofunction is thought to contribute to social, cognitive and gamma (30-80 Hz) oscillatory abnormalities, phenotypes common to these disorders. However, circuit-level mechanisms underlying such deficits remain unclear. This study investigated the relationship between gamma synchrony, excitatory-inhibitory (E/I) signaling, and behavioral phenotypes in NMDA-NR1(neo-/-) mice, which have constitutively reduced expression of the obligate NR1 subunit to model disrupted developmental NMDAR function. Constitutive NMDAR-hypofunction caused a loss of E/I balance, with an increase in intrinsic pyramidal cell excitability and a selective disruption of parvalbumin-expressing interneurons. Disrupted E/I coupling was associated with deficits in auditory-evoked gamma signal-to-noise ratio (SNR). Gamma-band abnormalities predicted deficits in spatial working memory and social preference, linking cellular changes in E/I signaling to target behaviors. The GABA(B)-receptor agonist baclofen improved E/I balance, gamma-SNR and broadly reversed behavioral deficits. These data demonstrate a clinically relevant, highly translatable neural-activity-based biomarker for preclinical screening and therapeutic development across a broad range of disorders that share common endophenotypes and disrupted NMDA-receptor signaling.
Collapse
Affiliation(s)
- M J Gandal
- Translational Neuroscience Program, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
| | - J Sisti
- Translational Neuroscience Program, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
| | - K Klook
- Translational Neuroscience Program, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA,Department of Psychiatry and Psychotherapy, RWTH Aachen University, Aachen, Germany
| | - P I Ortinski
- Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
| | - V Leitman
- Translational Neuroscience Program, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
| | - Y Liang
- Translational Neuroscience Program, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
| | - T Thieu
- Translational Neuroscience Program, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
| | - R Anderson
- Translational Neuroscience Program, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
| | - R C Pierce
- Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
| | - G Jonak
- Translational Neuroscience Program, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
| | - R E Gur
- Neuropsychiatry Program, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
| | - G Carlson
- Center for Neurobiology and Behavior, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA
| | - S J Siegel
- Translational Neuroscience Program, Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA,Director, Translational Neuroscience Program, Department of Psychiatry, University of Pennsylvania, Translational Research Laboratories, 125 S. 31st Street, Philadelphia, PA 19104, USA. E-mail: or
| |
Collapse
|